Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report

Hypokalemia can cause abnormalities in multiple systems. Long term use of antipsychotic medications can lead to electrolyte imbalance, including hypokalemia. We report a 49-year-old female patient with schizophrenia who developed hypokalemia after oral quetiapine and risperidone treatments. Her bloo...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410402/
https://www.ncbi.nlm.nih.gov/pubmed/30858673
http://dx.doi.org/10.11919/j.issn.1002-0829.217168
_version_ 1783402239652528128
collection PubMed
description Hypokalemia can cause abnormalities in multiple systems. Long term use of antipsychotic medications can lead to electrolyte imbalance, including hypokalemia. We report a 49-year-old female patient with schizophrenia who developed hypokalemia after oral quetiapine and risperidone treatments. Her blood potassium became normal after she switched to another antipsychotic drug (amisulpride). In addition, we discuss the potential mechanism of antipsychotic drugs leading to hypokalemia and clinical cautions.
format Online
Article
Text
id pubmed-6410402
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shanghai Municipal Bureau of Publishing
record_format MEDLINE/PubMed
spelling pubmed-64104022019-03-11 Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report Shanghai Arch Psychiatry Case Report Hypokalemia can cause abnormalities in multiple systems. Long term use of antipsychotic medications can lead to electrolyte imbalance, including hypokalemia. We report a 49-year-old female patient with schizophrenia who developed hypokalemia after oral quetiapine and risperidone treatments. Her blood potassium became normal after she switched to another antipsychotic drug (amisulpride). In addition, we discuss the potential mechanism of antipsychotic drugs leading to hypokalemia and clinical cautions. Shanghai Municipal Bureau of Publishing 2018-06-25 2018-06-25 /pmc/articles/PMC6410402/ /pubmed/30858673 http://dx.doi.org/10.11919/j.issn.1002-0829.217168 Text en © Shanghai Municipal Bureau of Publishing http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Case Report
Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title_full Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title_fullStr Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title_full_unstemmed Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title_short Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
title_sort hypokalemia caused by quetiapine and risperidone treatment in schizophrenia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410402/
https://www.ncbi.nlm.nih.gov/pubmed/30858673
http://dx.doi.org/10.11919/j.issn.1002-0829.217168
work_keys_str_mv AT hypokalemiacausedbyquetiapineandrisperidonetreatmentinschizophreniaacasereport
AT hypokalemiacausedbyquetiapineandrisperidonetreatmentinschizophreniaacasereport
AT hypokalemiacausedbyquetiapineandrisperidonetreatmentinschizophreniaacasereport

Ejemplares similares